Study on an innovative natural drug for Alzheimer's disease reported as a sham
The number of patients with dementia is estimated to be as high as 24 million and is predicted to double every 20 years, i.e., by 2040, leading to a tremendous financial disease burden. Therefore, we urgently need to identify drugs that can prevent, delay the onset, slow the progression, or improve...
Main Author: | Editor Group of Traditional Medicine Research |
---|---|
Format: | Article |
Language: | English |
Published: |
Hong Kong Gold Orchid Science and Technology Co., Limited
2020-09-01
|
Series: | Traditional Medicine Research |
Subjects: | |
Online Access: | https://www.tmrjournals.com/plus/view.php?aid=1522 |
Similar Items
-
Overlap between frontotemporal dementia and Alzheimer’s disease: case report
by: Maria Elena Di Battista, et al.
Published: (2017-07-01) -
Therapeutic Effects of Natural Drugs on Alzheimer’s Disease
by: Yuan Ma, et al.
Published: (2019-12-01) -
Determinants of clinical progress in Alzheimer's disease.
Published: (2005) -
Tu Youyou:A scientist moving forward in controversy
by: Editor Group of Traditional Medicine Research
Published: (2019-11-01) -
Exposure to gamma tACS in Alzheimer’s disease: A randomized, double-blind, sham-controlled, crossover, pilot study
by: Alberto Benussi, et al.
Published: (2021-05-01)